Oncimmune (ONC) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider TradesBuy This Stock Oncimmune (LON:ONC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.97%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)£24,847.01Number OfInsiders Selling(Last 3 Years)0 Get ONC Insider Trade Alerts Want to know when executives and insiders are buying or selling Oncimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ONC Insider Buying and Selling by Quarter Oncimmune Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/8/2023Martin GouldstoneInsiderBuy36,023GBX 27£9,726.216/5/2023Adam HillInsiderBuy48,370GBX 21£10,157.709/21/2022Adam HillInsiderBuy8,005GBX 62£4,963.10 (Data available from 1/1/2013 forward) ONC Insider Trading Activity - Frequently Asked Questions Who is on Oncimmune's Insider Roster? The list of insiders at Oncimmune includes Adam Hill, and Martin Gouldstone. Learn more on insiders at ONC. What percentage of Oncimmune stock is owned by insiders? 30.97% of Oncimmune stock is owned by insiders. Learn more on ONC's insider holdings. Which Oncimmune insiders have been buying company stock? The following insiders have purchased ONC shares in the last 24 months: Adam Hill (£10,157.70), and Martin Gouldstone (£9,726.21). How much insider buying is happening at Oncimmune? Insiders have purchased a total of 84,393 ONC shares in the last 24 months for a total of £19,883.91 bought. Oncimmune Key ExecutivesMr. Martin John Gouldstone (Age 58)CEO & Director Mr. Martin HudsonFinance DirectorMr. Ron Kirschner (Age 45)COO, General Counsel & Company Secretary Prof. Tariq Sethi B.Sc.FRCP, M.A., M.D., Ph.D., Chief Scientific OfficerMs. Cléa RosenfeldHead of Investor RelationsMr. Maarten BrusseChief Commercial Officer of Asia More Insider Trading Tools from MarketBeat Related Companies DEST Insider Selling ROQ Insider Selling OCTP Insider Selling GNS Insider Selling ONT Insider Selling OXB Insider Selling 4BB Insider Selling BVXP Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (LON:ONC) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncimmune Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ONC Stock Free ONC Stock Alerts